vs
亚什兰（ASH）与Tempus AI, Inc.（TEM）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是Tempus AI, Inc.的1.1倍（$386.0M vs $367.2M），亚什兰净利率更高（-3.1% vs -14.8%，领先11.6%），Tempus AI, Inc.同比增速更快（83.0% vs -4.7%），亚什兰自由现金流更多（$111.0M vs $-41.5M），过去两年Tempus AI, Inc.的营收复合增速更高（58.7% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
Tempus AI是2015年由埃里克·莱夫科夫斯基在美国伊利诺伊州芝加哥创立的医疗科技企业，创立契机源于其妻子确诊乳腺癌。公司依托数据与人工智能技术，为肿瘤、心脏病、放射医学、抑郁症等领域提供包含诊断在内的精准医疗服务，2024年6月14日于纳斯达克上市，股票代码为TEM。
ASH vs TEM — 直观对比
营收规模更大
ASH
是对方的1.1倍
$367.2M
营收增速更快
TEM
高出87.7%
-4.7%
净利率更高
ASH
高出11.6%
-14.8%
自由现金流更多
ASH
多$152.5M
$-41.5M
两年增速更快
TEM
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $367.2M |
| 净利润 | $-12.0M | $-54.2M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -1.6% | -16.7% |
| 净利率 | -3.1% | -14.8% |
| 营收同比 | -4.7% | 83.0% |
| 净利润同比 | 92.7% | -316.2% |
| 每股收益（稀释后） | $-0.26 | $-0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHTEM
| Q4 25 | $386.0M | $367.2M | ||
| Q3 25 | $477.0M | $334.2M | ||
| Q2 25 | $463.0M | $314.6M | ||
| Q1 25 | $479.0M | $255.7M | ||
| Q4 24 | $405.0M | $200.7M | ||
| Q3 24 | $521.0M | $180.9M | ||
| Q2 24 | $544.0M | $166.0M | ||
| Q1 24 | $575.0M | $145.8M |
净利润ASHTEM
| Q4 25 | $-12.0M | $-54.2M | ||
| Q3 25 | $31.0M | $-80.0M | ||
| Q2 25 | $-742.0M | $-42.8M | ||
| Q1 25 | $31.0M | $-68.0M | ||
| Q4 24 | $-165.0M | $-13.0M | ||
| Q3 24 | $17.0M | $-75.8M | ||
| Q2 24 | $6.0M | $-552.2M | ||
| Q1 24 | $120.0M | $-64.7M |
毛利率ASHTEM
| Q4 25 | 27.2% | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 28.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 33.2% | — | ||
| Q2 24 | 34.2% | — | ||
| Q1 24 | 28.0% | — |
营业利润率ASHTEM
| Q4 25 | -1.6% | -16.7% | ||
| Q3 25 | 12.8% | -18.3% | ||
| Q2 25 | -152.9% | -19.6% | ||
| Q1 25 | 10.6% | -26.9% | ||
| Q4 24 | -44.2% | -25.3% | ||
| Q3 24 | 6.1% | -29.6% | ||
| Q2 24 | -11.2% | -321.4% | ||
| Q1 24 | 3.7% | -36.5% |
净利率ASHTEM
| Q4 25 | -3.1% | -14.8% | ||
| Q3 25 | 6.5% | -23.9% | ||
| Q2 25 | -160.3% | -13.6% | ||
| Q1 25 | 6.5% | -26.6% | ||
| Q4 24 | -40.7% | -6.5% | ||
| Q3 24 | 3.3% | -41.9% | ||
| Q2 24 | 1.1% | -332.7% | ||
| Q1 24 | 20.9% | -44.4% |
每股收益（稀释后）ASHTEM
| Q4 25 | $-0.26 | $-0.30 | ||
| Q3 25 | $0.83 | $-0.46 | ||
| Q2 25 | $-16.21 | $-0.25 | ||
| Q1 25 | $0.65 | $-0.40 | ||
| Q4 24 | $-3.50 | $2.56 | ||
| Q3 24 | $0.34 | $-0.46 | ||
| Q2 24 | $0.12 | $-6.86 | ||
| Q1 24 | $2.39 | $-1.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $604.8M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $1.9B | $491.3M |
| 总资产 | $4.5B | $2.3B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资ASHTEM
| Q4 25 | $304.0M | $604.8M | ||
| Q3 25 | $215.0M | $655.9M | ||
| Q2 25 | $207.0M | $186.3M | ||
| Q1 25 | $168.0M | $151.6M | ||
| Q4 24 | $219.0M | $341.0M | ||
| Q3 24 | $300.0M | $388.0M | ||
| Q2 24 | $399.0M | $478.8M | ||
| Q1 24 | $439.0M | $79.9M |
总债务ASHTEM
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | — |
股东权益ASHTEM
| Q4 25 | $1.9B | $491.3M | ||
| Q3 25 | $1.9B | $507.8M | ||
| Q2 25 | $1.9B | $309.6M | ||
| Q1 25 | $2.6B | $326.2M | ||
| Q4 24 | $2.6B | $56.3M | ||
| Q3 24 | $2.9B | $53.7M | ||
| Q2 24 | $3.0B | $98.3M | ||
| Q1 24 | $3.1B | $-1.5B |
总资产ASHTEM
| Q4 25 | $4.5B | $2.3B | ||
| Q3 25 | $4.6B | $2.3B | ||
| Q2 25 | $4.6B | $1.6B | ||
| Q1 25 | $5.2B | $1.5B | ||
| Q4 24 | $5.2B | $926.1M | ||
| Q3 24 | $5.6B | $971.7M | ||
| Q2 24 | $5.7B | $864.6M | ||
| Q1 24 | $5.9B | — |
负债/权益比ASHTEM
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 0.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $-36.8M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $-41.5M |
| 自由现金流率自由现金流/营收 | 28.8% | -11.3% |
| 资本支出强度资本支出/营收 | 3.6% | 1.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $200.0M | $-239.1M |
8季度趋势，按日历期对齐
经营现金流ASHTEM
| Q4 25 | $125.0M | $-36.8M | ||
| Q3 25 | $40.0M | $-119.8M | ||
| Q2 25 | $115.0M | $44.2M | ||
| Q1 25 | $9.0M | $-105.6M | ||
| Q4 24 | $-30.0M | — | ||
| Q3 24 | $80.0M | $48.7M | ||
| Q2 24 | $127.0M | $-97.1M | ||
| Q1 24 | $54.0M | $-101.4M |
自由现金流ASHTEM
| Q4 25 | $111.0M | $-41.5M | ||
| Q3 25 | $6.0M | $-126.5M | ||
| Q2 25 | $95.0M | $36.6M | ||
| Q1 25 | $-12.0M | $-107.7M | ||
| Q4 24 | $-53.0M | — | ||
| Q3 24 | $42.0M | $48.6M | ||
| Q2 24 | $98.0M | $-105.1M | ||
| Q1 24 | $20.0M | $-107.5M |
自由现金流率ASHTEM
| Q4 25 | 28.8% | -11.3% | ||
| Q3 25 | 1.3% | -37.9% | ||
| Q2 25 | 20.5% | 11.6% | ||
| Q1 25 | -2.5% | -42.1% | ||
| Q4 24 | -13.1% | — | ||
| Q3 24 | 8.1% | 26.9% | ||
| Q2 24 | 18.0% | -63.3% | ||
| Q1 24 | 3.5% | -73.7% |
资本支出强度ASHTEM
| Q4 25 | 3.6% | 1.3% | ||
| Q3 25 | 7.1% | 2.0% | ||
| Q2 25 | 4.3% | 2.4% | ||
| Q1 25 | 4.4% | 0.8% | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 7.3% | 0.0% | ||
| Q2 24 | 5.3% | 4.8% | ||
| Q1 24 | 5.9% | 4.2% |
现金转化率ASHTEM
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.71× | — | ||
| Q2 24 | 21.17× | — | ||
| Q1 24 | 0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
TEM
暂无分部数据
